A preclinical trial of sialic acid metabolites on distal myopathy with rimmed vacuoles/ hereditary inclusion body myopathy, a sugar-deficient myopathy: A review

Therapeutic Advances in Neurological Disorders

Volumn 3, Issue 2, 2010, Pages 127-135

  Malicdan, May Christine V ^a   Noguchi, Satoru ^a   Nishino, Ichizo ^a  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

Author keywords

amyloid; GNE; muscular dystrophy; sialic acid; therapy

Indexed keywords

2 EPIMERASE N ACETYLMANNOSAMINE; CYTIDINE MONOPHOSPHATE NEURAMINATE; SIALIC ACID; SUGAR; UNCLASSIFIED DRUG;

DISTAL MYOPATHY; DISTAL MYOPATHY WITH RIMMED VACUOLES; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; DRUG METABOLISM; HEREDITARY INCLUSION BODY MYOPATHY; IN VIVO STUDY; LOW DRUG DOSE; MUTATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; THERAPY EFFECT; TOXICOLOGY;

EID: 77953445808     PISSN: 17562856     EISSN: None     Source Type: Journal    
DOI: 10.1177/1756285609359546     Document Type: Review

References (29)

1. Amsili, S., Shlomai, Z., Levitzki, R., Krause, S., Lochmuller, H., Ben-Bassat, H. et al. (2007) Characterization of hereditary inclusion body myopathy myoblasts: possible primary impairment of apoptotic events. Cell Death Differ 14: 1916-1924.
2. Argov, Z. and Yarom, R. ( 1984) ‘Rimmed vacuole myopathy’ sparing the quadriceps. A unique disorder in Iranian Jews. J Neurol Sci 64: 33-43.
3. Bardor, M., Nguyen, D.H., Diaz, S. and Varki, A. ( 2005) Mechanism of uptake and incorporation of the non-human sialic acid N-glycolylneuraminic acid into human cells. J Biol Chem 280: 4228-4237.
4. Carlson, S.E. and House, S.G. ( 1986) Oral and intraperitoneal administration of N-acetylneuraminic acid: effect in rat cerebral and cerebellar N-acetylneuraminic acid. J Nutr 116: 881-886.
5. Eisenberg, I., Avidan, N., Potikha, T., Hochner, H., Chen, M., Olender, T. et al. (2001) The UDP-N-acetylglucosamine 2-epimerase/ N-acetylmannosamine kinase gene is mutated in recessive hereditary inclusion body myopathy. Nat Genet 29: 83-87.
6. Gagiannis, D., Gossrau, R., Reutter, W., Zimmermann-Kordmann, M. and Horstkorte, R. ( 2007) Engineering the sialic acid in organs of mice using N-propanoylmannosamine. Biochim Biophys Acta 1770: 297-306.
7. Galeano, B., Klootwijk, R., Manoli, I., Sun, M., Ciccone, C., Darvish, D. et al. (2007) Mutation in the key enzyme of sialic acid biosynthesis causes severe glomerular proteinuria and is rescued by N-acetylmannosamine. J Clin Invest 117: 1585-1594.
8. Hinderlich, S., Berger, M., Keppler, O.T., Pawlita, M. and Reutter, W. ( 2001) Biosynthesis of N-acetylneuraminic acid in cells lacking UDP-N-acetylglucosamine 2-epimerase/ N-acetylmannosamine kinase. Biol Chem 382: 291-297.
9. Hinderlich, S., Salama, I., Eisenberg, I., Potikha, T., Mantey, L.R., Yarema, K.J. et al. (2004) The homozygous M712T mutation of UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase results in reduced enzyme activities but not in altered overall cellular sialylation in hereditary inclusion body myopathy. FEBS Lett 566: 105-109.
10. Hirschberg, C.B., Goodman, S.R. and Green, C. ( 1976) Sialic acid uptake by fibroblasts. Biochemistry 15: 3591-3599.
11. Hong, Y. and Stanley, P. ( 2003) Lec 3 Chinese hamster ovary mutants lack UDP-N-acetylglucosamine 2-epimerase activity because of mutations in the epimerase domain of the Gne gene. J Biol Chem 278: 53045-53054.
12. Keppler, O.T., Hinderlich, S., Langner, J., Schwartz-Albiez, R., Reutter, W. and Pawlita, M. ( 1999) UDP-GlcNAc 2-epimerase: a regulator of cell surface sialylation. Science 284: 1372-1376.
13. Malicdan, M.C., Noguchi, S., Hayashi, Y.K., Nonaka, I. and Nishino, I. (2009) Prophylactic treatment with sialic acid metabolites preclude the development of a myopathic phenotype in the DMRV-hIBM mouse model. Nat Med 15: 690-695.
14. Malicdan, M.C., Noguchi, S., Hayashi, Y.K. and Nishino, I. ( 2008) Muscle weakness correlates with muscle atrophy and precedes the development of inclusion body or rimmed vacuoles in the mouse model of DMRV/hIBM. Physiol Genomics 17: 106-115.
15. Malicdan, M.C., Noguchi, S. and Nishino, I. ( 2007a) Autophagy in a mouse model of distal myopathy with rimmed vacuoles or hereditary inclusion body myopathy. Autophagy 3: 396-398.
16. Malicdan, M.C., Noguchi, S., Nonaka, I., Hayashi, Y.K. and Nishino, I. ( 2007b) A Gne knockout mouse expressing human GNE D176V mutation develops features similar to distal myopathy with rimmed vacuoles or hereditary inclusion body myopathy. Hum Mol Genet 16: 2669-2682.
17. Nishino, I., Malicdan, M.C., Murayama, K., Nonaka, I., Hayashi, Y.K. and Noguchi, S. ( 2005) Molecular pathomechanism of distal myopathy with rimmed vacuoles. Acta Myol 24: 80-83.
18. Nishino, I., Noguchi, S., Murayama, K., Driss, A., Sugie, K., Oya, Y. et al. (2002) Distal myopathy with rimmed vacuoles is allelic to hereditary inclusion body myopathy. Neurology 59: 1689-1693.
19. Noguchi, S., Keira, Y., Murayama, K., Ogawa, M., Fujita, M., Kawahara, G. et al. (2004) Reduction of UDP-N-acetylglucosamine 2-epimerase/ N-acetylmannosamine kinase activity and sialylation in distal myopathy with rimmed vacuoles. J Biol Chem 279: 11402-11407.
20. Nonaka, I., Noguchi, S. and Nishino, I. ( 2005) Distal myopathy with rimmed vacuoles and hereditary inclusion body myopathy. Curr Neurol Neurosci Rep 5: 61-65.
21. Nöule, U. and Schauer, R. ( 1981) Uptake, metabolism and excretion of orally and intravenously administered, 14C- and 3H-labeled N-acetylneuraminic acid mixture in the mouse and rat. Hoppe Seylers Z Physiol Chem 362: 1495-1506.
22. Oetke, C., Hinderlich, S., Brossmer, R., Reutter, W., Pawlita, M. and Keppler, O.T. ( 2001) Evidence for efficient uptake and incorporation of sialic acid by eukaryotic cells. Eur J Biochem 268: 4553-4561.
23. Ritskes-Hoitinga, M. ( 2004) Nutrition of laboratory mice. In: Hedrich, H. and Bullock, G. (eds). The laboratory mouse. Elsevier Academic Press: London.
24. Salama, I., Hinderlich, S., Shlomai, Z., Eisenberg, I., Krause, S., Yarema, K. et al. (2005) No overall hypo-sialylation in hereditary inclusion body myopathy myoblasts carrying the homozygous M712T GNE mutation. Biochem Biophys Res Commun 328: 221-226.
25. Schwartz, E.L., Hadfield, A.F., Brown, A.E. and Sartorelli, A.C. ( 1983) Modification of sialic acid metabolism of murine erythroleukemia cells by analogs of N-acetylmannosamine. Biochem Biophys Acta 762: 489-497.
26. Schwarzkopf, M., Knobeloch, K.P., Rohde, E., Hinderlich, S., Wiechens, N., Lucka, L. et al. (2002) Sialylation is essential for early development in mice. Proc Natl Acad Sci U S A 99: 5267-5270.
27. Sparks, S., Rakocevic, G., Joe, G., Manoli, I., Shrader, J., Harris-Love, M. et al. (2007) Intravenous immune globulin in hereditary inclusion body myopathy: a pilot study. BMC Neurol 7: 3.
28. Yamaguchi, S., Ohnishi, J., Maru, I. and Ohta, Y. ( 2006) Simple and large-scale production of N-acetylneuraminic acid and N-acetyl-D-mannosamine. Trends Glycosci Glycotechnol 18: 245-252.
29. Wang, Z., Sun, Z., Li, A.V. and Yarema, K.J. ( 2006) Roles for GNE outside of sialic acid biosynthesis: modulation of sialyltransferase and BiP expression, GM 3 and GD 3 biosynthesis, proliferation and apoptosis, and ERK1/2 phosphorylation. J Biol Chem 281: 27016-27028.